Rebecca (Becky) Pferdehirt
Investment Partner at Andreessen Horowitz
Rebecca (becky) Pferdehirt
Investment Partner at Andreessen Horowitz
Montara, California
Overview
Work Experience
Investment Partner
2021 - Current
Investing in and supporting entrepreneurs building at the intersection of biology, technology and healthcare.
Andreessen Horowitz is a stage-agnostic venture capital firm with assets under management across multiple funds.
Senior Manager | Business Development
2017 - 2021
External R&D technology licensing and business development
Scientist | Discovery Research
2016 - 2017
Genome Analysis Unit Developing novel technologies for cell and gene therapies
Amgen is a biotechnology company that develops and manufactures human therapeutics for various illnesses and diseases.
Raised $28,500,000,000.00 from Citibank and Bank of America.
Postdoctoral Research Fellow
2011 - 2015
Postdoctoral research in the Microchemistry and Proteomics group, studying diverse post-translational modifications and their importance in cancer biology.
Genentech specializes in genetic testing and personalized medicine.
PhD Student in Molecular and Cellular Biology, Department of Genetics, Genomics and Development
2005 - 2011
Graduate research in Barbara Meyer's lab investigating SUMOylation and regulation of eukaryotic gene expression through study of C. elegans dosage compensation
Research Scientist
2004 - 2005
Product development and novel application testing/QA.
Promega products are used by life scientists who are asking fundamental questions about biological processes/
Undergraduate Research Assistant
2003 - 2004
Investigating the role of S. cerevisiae Spo13 in maintenance of centromeric cohesion during meiosis.
Research Intern
2003 - 2003
Summer intern in the lab of Shahragim Tajbakhsh studying the role of Pax7 in mouse embryonic muscle stem cell development.